Trial Profile
PHARMACOKINETICS AND PHARMACODYNAMICS OF LETAXABAN, A NOVEL FACTOR XA INHIBITOR, IN HEALTHY MALE JAPANESE SUBJECTS
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Aug 2011
Price :
$35
*
At a glance
- Drugs Letaxaban (Primary)
- Indications Thrombosis
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Takeda
- 08 Aug 2011 New trial record